Enfermedad de Coats, presentación de un Caso y revisión de la literatura

Bernardo Quijano Nieto, Sandra Juliana Peñaloza Suárez, Alba Pérez Murillo

Resumen


La enfermedad de Coats, es una vasculopatía retiniana idiopática que sin tratamiento puede progresar a desprendimiento de retina exudativo y glaucoma neovascular. Se considera una patología de difícil diagnóstico, por su presentación clínica que simula otras vasculopatías retinianas ó retinoblastoma. Resulta indispensable contar con herramientas clínicas y paraclínicas para llegar a un diagnóstico acertado y poder realizar un manejo adecuado y oportuno. Presentamos el caso de un niño de 17 años, con enfermedad de Coats valorado y tratado en el Hospital Militar Central de Bogotá desde los 5 años de edad; se realiza seguimiento clínico de 12 años de evolución y se discuten posibles diagnósticos diferenciales.


Palabras clave


Enfermedad de Coats, telangiectasias retinianas, fotocoagulación láser, antiangiogénicos.

Texto completo:

PDF

Referencias


Shields JA, Shields CL. Diff erentiation of coats disease and retinoblastoma. JAAPOS 2001;38:262.

Ryan, S. J., & Retina, M. R. (2013). Volúmen 2: Enfermedades vasculares retinianas. Sección II: Enfermedad de Coats. Pags. 1058-1069.

Lim Fat CP, Lee SY, Brundler MA, Scott CM, Parulekar MV. Coats disease in a 3-week-old boy. J AAPOS 2014;18:86-8.

Kaufman PL, Saunders RA. Approach to the child with leukocoria. UpToDate. Waltham, MA:UpToDate; Last Updated November 2012.

Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG. Current management of coats disease. Surv Ophthalmol 2014;59:30-46.

Sims KB. NDP-Related retinopathies. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle; 1993.

Ye X, Smallwood P, Nathans J. Expression of the Norrie disease gene (ndp) in developing and adult mouse eye, ear, and brain. Gene Expr Patterns 2011;11:151-5.

Th e expanding roles of ABCA4 and CRB1 in inherited blindness; Retinal dystrophies: Functional genomics to gene therapy: Novartis foundation symposium 255. 2004.

den Hollander AI, Davis J, van der Velde-Visser SD, Zonneveld MN, Pierrottet CO, Koenekoop RK, et al. CRB1 mutation spectrum in inherited retinal dystrophies. Hum Mutat 2004;24:355-69.

Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ. Pearls and pitfalls in diagnosis and management of Coats disease. Retina 2015;35:614-23.

Martínez-Castillo S, Gallego-Pinazo R, Dolz-Marco R, Marín-Lambíes C, Díaz-Llopis M. Adult Coats disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation. C Rep Ophthalmol 2012;3:123-7.

Mishra A, Aggarwal S, Shah S, Negi P, Bharwada R, Desai N. An interesting case of Coats’ disease. Medical Journal Armed Forces India 2015;71:384-388.

Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF. Coats’ disease diagnosed in adulthood. Ophthalmology 2005;112:1072-8.

Jonas JB, Holbach LM. Clinical-pathologic correlation in Coats’ disease. Graefe’s Arch Clin Exp Ophthalmol 2001;239:544-5.

Kremer I, Nissenkorn I, Ben-Sira I. Cytologic and biochemical examination of the subretinal fluid in diagnosis of Coats’ disease. Acta Ophthalmologica 1989;67:342-6.

Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of coats disease in 150 cases: The 2000 sanford giff ord memorial lecture. Am J Ophthalmol 2001;131:561-71.

Shapiro MJ, Chow CC, Karth PA, Kiernan DF, Blair MP. Effects of green diode laser in the treatment of pediatric coats disease. Am J Ophthalmol 2011;151:725-731.e2.

Long G, Stringer DA, Nadel HR, Fink AM, Lewis P, Carruthers JD, Lyons C. B mode ultrasonography spectrum of paediatric ocular disease. Eur J Radiol 1998;26:132-47.

Kodama A, Sugioka K, Kusaka S, Matsumoto C, Shimomura Y. Combined treatment for Coats’ disease: Retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases. BMC Ophthalmol 2014;14:36.

Villegas VM, Gold AS, Berrocal AM, Murray TG. Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin Ophthalmol 2014;8:973-6.

Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: The 2000 proctor lecture. Am J Ophthalmol 2001;131:572-83.

Ghazi NG, Al Shamsi H, Larsson J, Abboud E. Intravitreal triamcinolone in Coats’ disease. Ophthalmology 2012;119:648-9.

Balmer A, Munier F. Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma. Clinical Ophthalmology (Auckland, NZ) 2007;1:431.

Kaufman LM, Mafee MF, Song CD. Retinoblastoma and simulating lesions: Role of CT, MR imaging and use of gd-dtpa contrast enhancement. Radiol Clin North America 1998;36:1101-17.

Houston SK, Murray TG, Wolfe SQ, Fernandes CE. Current update on retinoblastoma. Int Ophthalmol Clin 2011;51:77-91.

Silbert M, Gurwood AS. Persistent hyperplastic primary vitreous. Clin Eye Vis Care 2000;12:131-7.

Müllner-Eidenböck A, Amon M, Moser E, Klebermass N. Persistent fetal vasculature and minimal fetal vascular remnants: A frequent cause of unilateral congenital cataracts. Ophthalmology 2004;111:906-13.

Davis J, Schecter SH, Sowka J. Eales’ disease: The great masquerader. Optometry 2009;80:354-9.

Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales disease—an update. Surv Ophthalmol 2002;47:197-214.


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2017 Revista Sociedad Colombiana de Oftalmología

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.